TABLE 6.

Persistence of NS5A RAMs through postdose week 12, 24, or 48

GT	Dose	Patient	RAM(s) persistent up to wk 48 (%)a
1a	10	5306	UNK
	10	5310	Q30H(1)/R(37), L31M(43), H58D(2), Y93N(7)/C(8)
	10	5314	Q30H(56)/R(13), F36L(1)
	10	5407b	K24R(2), M28V(66), Q30H(8)/R(80), L31M(2), H58C(15)/D(2), Y93F(12)
	30	5303	Q30H(14)/R(79), H58D(3)
	30	5307	ND
	30	5313	UNK
	100	5301	M28T(2), L31M(77)
	100	5308	M28T(5)/V(4), Q30H(2)/R(78), L31M (1), Y93C(2)
	100	5311c	M28T(63), Q30R(53)
	200	5304	UNK
	200	5305	UNK
	200	5309	UNK
1b	10	5404	UNK
	10	5409	ND
	30	5405	Y93H(3)
	30	5413c	ND
	30	5414	Y93H(99)
	100	5402	L28 M(6), R30Q(16), L31 M(35), Y93H(37)/N(45)
	100	5406b	R30G(3), L31V(46)/M(2), Y93H(4)
	100	5410	L31M(12), Y93H(10)
	200	5403	UNK
	200	5408c	L31V(2)/M(97), Y93H(92)
	200	5411b	L28 M(58), R30Q(5)/H(95)

^aUNK, no data for week 12, 24, or 48; ND, no RAMs detected.

^bWeek 12 persistence.

^cWeek 24 persistence.